Department of Pathophysiology (AIDS Unit), Laikon General Hospital and Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Diagn Microbiol Infect Dis. 2012 Dec;74(4):409-11. doi: 10.1016/j.diagmicrobio.2012.08.009. Epub 2012 Sep 10.
We present 2 cases of HIV-related cryptococcal meningitis, persisting after 3 and 9 months, respectively, of standard treatment. Both patients were treated successfully with a salvage regimen consisting of the combination of liposomal amphotericin B (3 mg/kg), intravenous voriconazole, and subcutaneous recombinant interferon γ-1b (200 μg thrice weekly). Voriconazole was administered at an increased dose (5 mg/kg, twice daily) to overcome interactions with co-administered ritonavir. In both patients, resolution of clinical signs and symptoms, as well as sterilization of cerebrospinal fluid cultures occurred after 10 weeks of salvage therapy. No major side effects were encountered. At the end of treatment, both patients were placed on maintenance therapy with oral fluconazole; no recurrence has been observed after 4 years of follow-up.
我们报告 2 例 HIV 相关隐球菌性脑膜炎,分别在标准治疗后 3 个月和 9 个月持续存在。这两例患者均成功接受了挽救治疗,方案包括脂质体两性霉素 B(3 mg/kg)、静脉伏立康唑和皮下重组干扰素 γ-1b(每周 3 次,200 μg)。为了克服与同时给予的利托那韦的相互作用,伏立康唑的剂量增加至 5 mg/kg,每日 2 次。在这 2 例患者中,挽救治疗 10 周后,临床症状和体征均得到缓解,脑脊液培养也转为阴性。未出现主要不良反应。治疗结束时,这 2 例患者均接受了氟康唑口服维持治疗;随访 4 年后,均未复发。